1-47219953-T-C
Position:
Variant summary
Our verdict is Likely benign. Variant got -4 ACMG points: 2P and 6B. PM2BP4_ModerateBS2
The NM_001290403.2(TAL1):āc.763A>Gā(p.Lys255Glu) variant causes a missense change. The variant allele was found at a frequency of 0.00000379 in 1,320,058 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: š 0.0 ( 0 hom., cov: 30)
Exomes š: 0.0000038 ( 0 hom. )
Failed GnomAD Quality Control
Consequence
TAL1
NM_001290403.2 missense
NM_001290403.2 missense
Scores
7
12
Clinical Significance
Conservation
PhyloP100: 5.07
Genes affected
TAL1 (HGNC:11556): (TAL bHLH transcription factor 1, erythroid differentiation factor) Enables several functions, including DNA-binding transcription factor activity; E-box binding activity; and histone deacetylase binding activity. Involved in several processes, including myeloid cell differentiation; positive regulation of cellular component organization; and positive regulation of erythrocyte differentiation. Located in chromatin and nucleoplasm. Part of transcription regulator complex. Implicated in acute lymphoblastic leukemia. [provided by Alliance of Genome Resources, Apr 2022]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -4 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.23476186).
BS2
High AC in GnomAdExome4 at 5 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TAL1 | NM_001290403.2 | c.763A>G | p.Lys255Glu | missense_variant | 5/5 | ENST00000691006.1 | NP_001277332.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TAL1 | ENST00000691006.1 | c.763A>G | p.Lys255Glu | missense_variant | 5/5 | NM_001290403.2 | ENSP00000510655.1 | |||
TAL1 | ENST00000294339.3 | c.763A>G | p.Lys255Glu | missense_variant | 4/4 | 1 | ENSP00000294339.3 | |||
TAL1 | ENST00000371884.6 | c.763A>G | p.Lys255Glu | missense_variant | 5/5 | 1 | ENSP00000360951.1 | |||
TAL1 | ENST00000459729.1 | n.531A>G | non_coding_transcript_exon_variant | 3/3 | 1 |
Frequencies
GnomAD3 genomes AF: 0.00 AC: 0AN: 145564Hom.: 0 Cov.: 30 FAILED QC
GnomAD3 genomes
AF:
AC:
0
AN:
145564
Hom.:
Cov.:
30
FAILED QC
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.00000379 AC: 5AN: 1320058Hom.: 0 Cov.: 36 AF XY: 0.00000308 AC XY: 2AN XY: 649960
GnomAD4 exome
AF:
AC:
5
AN:
1320058
Hom.:
Cov.:
36
AF XY:
AC XY:
2
AN XY:
649960
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome Data not reliable, filtered out with message: AC0 AF: 0.00 AC: 0AN: 145564Hom.: 0 Cov.: 30 AF XY: 0.00 AC XY: 0AN XY: 70892
GnomAD4 genome
Data not reliable, filtered out with message: AC0
AF:
AC:
0
AN:
145564
Hom.:
Cov.:
30
AF XY:
AC XY:
0
AN XY:
70892
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 03, 2024 | The c.763A>G (p.K255E) alteration is located in exon 4 (coding exon 3) of the TAL1 gene. This alteration results from a A to G substitution at nucleotide position 763, causing the lysine (K) at amino acid position 255 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Uncertain
D
BayesDel_noAF
Uncertain
CADD
Benign
DANN
Uncertain
DEOGEN2
Benign
T;T
Eigen
Benign
Eigen_PC
Benign
FATHMM_MKL
Uncertain
D
LIST_S2
Benign
.;T
M_CAP
Benign
D
MetaRNN
Benign
T;T
MetaSVM
Uncertain
D
MutationAssessor
Benign
L;L
PrimateAI
Uncertain
T
PROVEAN
Benign
N;N
REVEL
Uncertain
Sift
Benign
T;T
Sift4G
Benign
T;T
Polyphen
P;P
Vest4
MutPred
Loss of ubiquitination at K255 (P = 0.0014);Loss of ubiquitination at K255 (P = 0.0014);
MVP
MPC
1.1
ClinPred
D
GERP RS
RBP_binding_hub_radar
RBP_regulation_power_radar
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at